Test | WEO (W1) | WEO (W2) | SEO (S1) | SEO (S2) | Piperazine citrate (Standard) |
---|---|---|---|---|---|
Time for paralysis (min.) | |||||
1% EO | 4.32 ± 0.45 aB | 4.01 ± 0.57 aB | 3.25 ± 0.35 bB | 3.03 ± 0.35 bB | 9.77 ± 0.78 A |
2% EO | 3.51 ± 0.52 aB | 3.66 ± 0.39 aB | 2.15 ± 0.25 aB | 2.59 ± 0.05 aB | |
3% EO | 2.37 ± 0.24 aB | 2.66 ± 0.14 aB | 1.75 ± 0.15 bB | 1.36 ± 0.21 bB | |
 | Time for death (min.) | ||||
1% EO | 6.25 ± 0.66 aB | 5.99 ± 0.85 aB | 5.58 ± 0.42 aB | 5.61 ± 0.36 aB | 13.58 ± 0.95 A |
2% EO | 4.65 ± 0.49 aB | 4.14 ± 0.41 aB | 4.22 ± 0.22 aB | 4.26 ± 0.45 aB | |
3% EO | 3.89 ± 0.42 aB | 3.63 ± 0.43 aB | 2.45 ± 0.19 bB | 2.41 ± 0.74 bB |